Comprehensive review of chemotherapy in patients with metastatic breast cancer [19]

Journal of Clinical Oncology

Volumn 23, Issue 31, 2005, Pages 8139-8140

  Melemed, Allen S ^a   Mockbee, Colleen ^a   Orlando, Mauro ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GEMCITABINE; PACLITAXEL;

BREAST CANCER; CANCER CHEMOTHERAPY; DRUG APPROVAL; DRUG INFORMATION; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; PRIORITY JOURNAL; BREAST TUMOR; DRUG THERAPY; FEMALE; METASTASIS; NOTE; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DRUG THERAPY; FEMALE; HUMANS; TREATMENT OUTCOME;

EID: 32944461272     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.02.6799     Document Type: Letter

References (2)

1. Hamilton A, Hortobagyi G: Chemotherapy: What progress in the last 5 years? J Clin Oncol 23:1760-1775, 2005
2. Guidance for Industry: FDA Approval of New Cancer Treatment Uses for Marketed and Biological Products. http://www.fda.gov/cder/guidance/ 1484fnl.pdf